Cardiol Therapeutics Inc (CRDL)
1.79
-0.05
(-2.72%)
USD |
NASDAQ |
Apr 24, 14:29
Cardiol Therapeutics Shareholders Equity (Quarterly): 21.29M for Dec. 31, 2023
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 21.29M |
| September 30, 2023 | 25.65M |
| June 30, 2023 | 29.24M |
| March 31, 2023 | 33.68M |
| December 31, 2022 | 38.46M |
| September 30, 2022 | 42.91M |
| June 30, 2022 | 48.78M |
| March 31, 2022 | 55.44M |
| December 31, 2021 | 59.79M |
| September 30, 2021 | 22.80M |
| June 30, 2021 | 27.21M |
| March 31, 2021 | 14.45M |
| Date | Value |
|---|---|
| December 31, 2020 | 10.41M |
| September 30, 2020 | 16.79M |
| June 30, 2020 | 19.11M |
| March 31, 2020 | 8.832M |
| December 31, 2019 | 11.23M |
| September 30, 2019 | 12.57M |
| June 30, 2019 | 14.92M |
| March 31, 2019 | 16.43M |
| December 31, 2018 | 16.35M |
| September 30, 2018 | -2.484M |
| December 31, 2017 | 2.270M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
8.832M
Minimum
Mar 2020
59.79M
Maximum
Dec 2021
27.03M
Average
22.80M
Median
Sep 2021
Shareholders Equity (Quarterly) Benchmarks
| Aurinia Pharmaceuticals Inc | 377.95M |
| Acasti Pharma Inc | 64.68M |
| Edesa Biotech Inc | 5.845M |
| Lexaria Bioscience Corp | 6.521M |
| Xenon Pharmaceuticals Inc | 927.92M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 27.67M |
| Total Liabilities (Quarterly) | 6.373M |